ENANTA PHARMACEUTICALS INC (ENTA) › Total LiabilitiesENANTA PHARMACEUTICALS INC (ENTA) — Total LiabilitiesAnnual figures by period end, from SEC filings.2012-09-30: $8.23M2013-09-30: $6.50M2014-09-30: $6.76M2015-09-30: $9.86M2016-09-30: $11.34M2017-09-30: $24.96M2018-09-30: $20.55M2019-09-30: $27.34M2020-09-30: $30.55M2021-09-30: $39.36M2022-09-30: $54.08M2023-09-30: $245.54M2024-09-30: $247.84M2025-09-30: $216.01M$216.01M2012-09-30Total Liabilities (USD)2025-09-30Period endedTotal LiabilitiesChange YoYSource filing2025-09-30$216.01M-12.8%2025-11-19Balance as of period end2024-09-30$247.84M+0.9%2025-11-19Balance as of period end2023-09-30$245.54M+354.1%2024-11-27Balance as of period end2022-09-30$54.08M+37.4%2023-11-22Balance as of period end2021-09-30$39.36M+28.8%2022-11-23Balance as of period end2020-09-30$30.55M+11.8%2021-11-24Balance as of period end2019-09-30$27.34M+33.0%2020-11-25Balance as of period end2018-09-30$20.55M-17.7%2019-11-27Balance as of period end2017-09-30$24.96M+120.1%2018-11-29Balance as of period end2016-09-30$11.34M+15.1%2017-12-11Balance as of period end2015-09-30$9.86M+45.8%2016-12-09Balance as of period end2014-09-30$6.76M+3.9%2015-12-11Balance as of period end2013-09-30$6.50M-21.0%2014-12-11Balance as of period end2012-09-30$8.23M—2013-12-18Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)